HR 6320 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Improving Medicaid Precision and Cancer Test Act of 2025
To amend title XIX of the Social Security Act to require coverage of lung cancer biomarker testing under the Medicaid program.
Summary
This bill amends the Medicaid program to require coverage of lung cancer biomarker testing. Biomarker testing helps identify specific characteristics of lung cancer tumors to guide treatment decisions. The bill expands Medicaid's coverage of medical services to include this testing, making it available to Medicaid-eligible patients. The changes take effect on January 1, 2027.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
3 cosponsors
Money behind the sponsor
Top reported contributors to Josh Gottheimer’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- BLACKSTONE $116,700
- APOLLO GLOBAL MANAGEMENT $71,500
- KKR & CO INC. $50,600
- CENTERVIEW PARTNERS $25,000
- FORTRESS INVESTMENT GROUP $23,200
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Josh Gottheimer → · Outside spending →
Actions (2)
- Nov 28, 2025 Referred to the House Committee on Energy and Commerce. · house
- Nov 28, 2025 Introduced in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
November 28, 2025
Mr. Gottheimer (for himself and Mr. Rutherford) introduced the following bill; which was referred to the Committee on Energy and Commerce
A BILL
To amend title XIX of the Social Security Act to require coverage of lung cancer biomarker testing under the Medicaid program.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Improving Medicaid Precision and Cancer Test Act of 2025”.
SEC. 2. REQUIRING COVERAGE OF LUNG CANCER BIOMARKER TESTING UNDER THE MEDICAID PROGRAM.
(a) In General.—Title XIX of the Social Security Act (42 U.S.C. 1396 et seq.) is amended—
(1) in section 1902(a)(10)(A), in the matter preceding clause (i), by striking “and (30)” and inserting “(30), and
(32)”;
(2) in section 1905—
(A) in subsection (a)—
(i) in paragraph (31), by striking “; and” and inserting a semicolon;
(ii) by redesignating paragraph (32) as paragraph (33); and
(iii) by inserting the following paragraph after paragraph (31):
“(32) lung cancer biomarker testing; and”; and
(3) in section 1937(b)(5), by inserting before the period at the end the following: “, and beginning January 1, 2027, coverage of lung cancer biomarker testing”.
(b) Effective Date.—The amendments made by this section shall apply beginning January 1, 2027. <all>
Comments